Policing practices are consistently associated with HIV and risk behaviours among people who inject drugs
First trial results of new immune-modulating drugs presented in Mexico City
Could integrating HIV prevention into contraceptive services reduce infections among African women?
Starting PrEP does not lead to more STIs, youth survey in Chicago finds
Who stops taking PrEP, and why?
Islatravir plus doravirine may offer new dual therapy option
Trial vaccine could protect against HIV for more than five years
Four days on, three days off HIV treatment as effective as continuous therapy, French study finds
ADVANCE trial shows dolutegravir is highly effective in South Africa
